Vaccines BACK TO HOME Market Model Innovation While perhaps not as lucrative or – prior to COVID-19 – as attention-grabbing – as other areas of the pharmaceutical industry, vaccines are also not the forgotten backwaters that many industry insiders seem to view them as. While the inherent…
HOMEPAGE Vaccines Long dismissed as the backwaters of healthcare innovation, the tremendous value of vaccines – the single most cost-effective health intervention after clean water – made itself starkly clear in 2020, as the discovery of a novel coronavirus quickly exploded into a full-blown global pandemic that rages on still.…
BACK TO HOME Cell & Gene Therapy BACK TO HOME RWE: Unlocking the Full potential of Cell & Gene Emerging cell and gene therapies herald immense clinical value for patients, society, and healthcare systems: carrying the potential to offer life-changing solutions for people with few or no…
BACK TO HOME Cell & Gene Therapy BACK TO HOME The Collaborative Spirit of Cell & Gene One of the more intriguing aspects about the new wave of cell and gene therapies (CGT) coming onstream is that they are not just technologically innovative in terms of the…
BACK TO HOME Cell & Gene Therapy BACK TO HOME Reconsidering Cell & Gene Therapies Manufacturing Advances in cell and gene therapies (CGT) are credited with thoroughly transforming medicinal science and creating an inflection point in the ability to treat and potentially cure many intractable illnesses. To…
BACK TO HOME Cell & Gene Therapy BACK TO HOME Introducing Cell & Gene Therapy Once considered almost science fiction in medicine, personalised medicine is increasingly becoming a day-to-day reality for many patients. Once considered almost science fiction in medicine, personalised medicine is increasingly becoming a day-to-day…
BACK TO HOME Cell & Gene Therapy BACK TO HOME Funding the Cell & Gene Therapy Boom The ascent of cell and gene therapies (CGT) is commonly regarded as one of the momentous turning points in the history of the pharmaceuticals industry. Not only do innovative therapies…
InFocus BACK TO HOME Cell & Gene Therapy BACK TO HOME Stefan Hendriks Global Head, Cell & Gene, Novartis Oncology Stefan Hendriks, Global Head of Novartis Oncology’s Cell & Gene division outlines the company’s progression to becoming the global leader in cell and gene therapies, the strategy he…
HOMEPAGE Cell & Gene Therapy Once considered almost science fiction in medicine, personalised medicine is increasingly becoming a day-to-day reality for many patients. As innovative pharma continues to invest heavily in high-risk frontier research involving stem cells and the harnessing of a patient’s own immune system to attack the onset…
2021 Patient Engagement in the Era of CAR-T In recent years, the much-discussed concept of “patient centricity” has been top-of-mind across all corners of the pharma industry. This is especially pertinent now that many innovative drug makers are seeking to become much… Featured Content Interview with Marc Boutin, Novartis Rendering…
See our Cookie Privacy Policy Here
